Screener
Bio-Rad Laboratories BIO Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Bio-Rad Laboratories’s 10-K, filed February 13, 2026.
- Filed
- Feb 12, 2026, 9:50 PM EST
- Fiscal year
- FY2025
- Accession
- 0000012208-26-000010
| Line item | December 31, 2025 | December 31, 2024 |
|---|---|---|
| Total current assets | 2,906.2 | 3,030.3 |
| Property, plant and equipment, net | 539.9 | 528.1 |
| Operating lease right-of-use assets | 170.0 | 160.5 |
| Goodwill, net | 579.8 | 410.5 |
| Purchased intangibles, net | 174.3 | 293.6 |
| Other investments | 6,103.6 | 4,839.2 |
| Other assets | 102.7 | 101.9 |
| Total assets | $10,576.5 | $9,364.1 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Bio-Rad Laboratories's deferred tax assets and other non-current assets?
- Bio-Rad Laboratories (BIO) reported deferred tax assets and other non-current assets of $102.7M in Q4 2025.
- How has Bio-Rad Laboratories's deferred tax assets and other non-current assets changed year-over-year?
- Bio-Rad Laboratories's deferred tax assets and other non-current assets increased by 0.8% year-over-year, from $101.9M to $102.7M.
- What is the long-term trend for Bio-Rad Laboratories's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's deferred tax assets and other non-current assets has grown at a 3.4% compound annual growth rate (CAGR), from $86.72M to $102.7M.
Ask your AI about Bio-Rad Laboratories's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude